Trial
NCT01391611
Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Kristen Ganjoo
Collaborators
GlaxoSmithKline
Condition
Gastrointestinal Stromal Tumor (GIST)
Intervention
Pazopanib
Why stopped
Lack of efficacy - Futility endpoint reached
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-07